| Sign In to gain access to subscriptions and/or personal tools. |
DOI: 10.1191/0269215502cr489oa © 2002 SAGE Publications Managing depression in brain injury rehabilitation: the use of an integrated care pathway and preliminary report of response to sertraline
Regional Rehabilitation Unit, Northwick Park and St Mark's Hospital Trust, Harrow, Middlesex, UK Aims: To use data generated from an integrated care pathway (ICP) to describe the characteristics of patients presenting with depression in a brain injury rehabilitation programme and to assess their response to treatment with sertraline. Setting: A regional rehabilitation unit providing inpatient rehabilitation for young patients (1665) with severe complex disabilities. Design: Prospective cohort study of 82 patients admitted to the unit during the 15-month period between between 1 September 1999 and 1 December 2000. Response to sertraline was assessed in an open-label, before-andafter study design Methods and design: All admissions were screened and included in the ICP if there was clinical suspicion of depression, past or present. Anti-depressant medication was prescribed, where appropriate, according to the ICP protocol. Depression was diagnosed on clinical grounds against DSM-IV criteria, and measured where feasible using the Beck Depression Inventory (BDI-II) administered by interview, pretreatment and at 68 weeks. Results: Of 82 admissions 41 (50%) were managed using the ICP and 27 (64%) were either started on or changed to sertraline 21 for depression ± lability and six for emotional lability only. All of the depressed patients improved clinically at some level and no signi"cant side-effects were observed. The BDI-II was assessable in 17/21 who showed a mean improvement of 14.5 ± 9.7 (con"dence interval (CI) 9.319.7, p < 0.001). Eleven patients (52%) had previously failed to respond with a different selective serotonin re-uptake inhibitor (SSRI) agent but still made a signi"cant response when changed to sertraline with a mean reduction in BDI-II of 16.3 ± 10.9 (CI 8.424.11, p < 0.001). Conclusions: The ICP was practical to use and provided systematic data on assessment of depression and response to treatment in real-life clinical practice in a brain injury rehabilitation setting. Sertraline appears to be useful and well-tolerated in this context. A full placebo-controlled study is now required.
This article has been cited by other articles:
|
||||||||||||||||||||||||||||||||||||||||||||||||


